You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The collaboration is aimed at evaluating new sample stabilization approaches for clinical applications with a focus on imaging mass spectrometry applications.
Denator said this week that it has named Karsten Fjärstedt vice president for global sales and marketing.
NEW YORK (GenomeWeb News) – Denator and two Dutch medical centers today announced a collaboration to develop a biomarker discovery platform for the diagnosis of cancer.
By Adam Bonislawski
A team led by scientists at the University of Texas MD Anderson Cancer Center has identified a panel of proteins linked to poor prognosis in hormone-receptor-positive breast cancer.
Swedish biotech firm Denator said this week it has completed its sixth financing round, securing €2.75 million ($3.66 million) in funding.
Activiomics announced this week it has appointed Trevor Nicholls to its board as a non-executive chairman.
NEW YORK (GenomeWeb News) – Swedish sample preparation firm Denator today announced it raised SEK25.5 million ($3.8 million) in a sixth round of financing.
NEW YORK (GenomeWeb News) – Denator today announced deals with three firms to distribute its products in Asia.
Brian Monahan, William Knight, John Ervin, Robert Fein, Martin Nicklasson
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.